Ramucirumab (IMC-1121B): a novel attack on angiogenesis

JL Spratlin, KE Mulder, JR Mackey - Future Oncology, 2010 - Taylor & Francis
Angiogenesis is a critical hallmark of malignancy, and attempts to inhibit this process have
characterized the age of biologic anticancer therapies for solid tumors. VEGF receptor-2 is …
被引用次数：87 相关文章

Ramucirumab (IMC-1121B): a novel attack on angiogenesis

JL Spratlin - Future Oncology, 2010 - search.proquest.com
Angiogenesis is a critical hallmark of malignancy, and attempts to inhibit this process have
characterized the age of biologic anticancer therapies for solid tumors. VEGF receptor-2 is …

Ramucirumab (IMC-1121B): a novel attack on angiogenesis

JL Spratlin, KE Mulder… - Future oncology …, 2010 - pubmed.ncbi.nlm.nih.gov
Angiogenesis is a critical hallmark of malignancy, and attempts to inhibit this process have
characterized the age of biologic anticancer therapies for solid tumors. VEGF receptor-2 is …

Ramucirumab (IMC-1121B): a novel attack on angiogenesis

JL Spratlin, KE Mulder, JR Mackey - Future Oncology, 2010 - cir.nii.ac.jp
抄録< jats: p> Angiogenesis is a critical hallmark of malignancy, and attempts to inhibit this
process have characterized the age of biologic anticancer therapies for solid tumors. VEGF …

Ramucirumab (IMC-1121B): a novel attack on angiogenesis.

JL Spratlin, KE Mulder, JR Mackey - Future Oncology (London …, 2010 - europepmc.org
Angiogenesis is a critical hallmark of malignancy, and attempts to inhibit this process have
characterized the age of biologic anticancer therapies for solid tumors. VEGF receptor-2 is …

Ramucirumab (IMC-1121B): a novel attack on angiogenesis

JL Spratlin, KE Mulder, JR Mackey - Future Oncology, 2010 - go.gale.com
Angiogenesis is the physiologic process of new blood vessel formation, which is co-opted by
many human malignancies to meet the metabolic requirements of macroscopic solid tumors …
[PDF] academia.edu

[PDF][PDF] g Eva lu

JL Spratlin, KE Mulder, JR Mackey - cancer - academia.edu
Drug Evaluation Spratlin, Mulder & Mackey breast cancer, glioblastoma and metastatic renal
cell carcinoma (RCC)[19–25]; although an overall survival advantage was seen in …